Economic aspects of deep sternal wound infections.

PubWeight™: 1.42‹?› | Rank: Top 5%

🔗 View Article (PMID 19896860)

Published in Eur J Cardiothorac Surg on November 06, 2009

Authors

Karolin Graf1, Ella Ott, Ralf-Peter Vonberg, Christian Kuehn, Axel Haverich, Iris Freya Chaberny

Author Affiliations

1: Institute for Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany. Graf.Karolin@MH-Hannover.DE

Articles citing this

Negative-pressure wound therapy for deep sternal wound infections reduces the rate of surgical interventions for early re-infections. Interact Cardiovasc Thorac Surg (2012) 1.30

Wound complications after median sternotomy: a single-centre study. Interact Cardiovasc Thorac Surg (2013) 1.24

The prevalence of nosocomial and community acquired infections in a university hospital: an observational study. Dtsch Arztebl Int (2013) 1.06

First experience with a new negative pressure incision management system on surgical incisions after cardiac surgery in high risk patients. J Cardiothorac Surg (2011) 0.96

Surgical site infections--economic consequences for the health care system. Langenbecks Arch Surg (2011) 0.93

Risk analysis and outcome of mediastinal wound and deep mediastinal wound infections with specific emphasis to omental transposition. J Cardiothorac Surg (2011) 0.93

A new cable-tie-based sternal closure device: infectious considerations. Interact Cardiovasc Thorac Surg (2013) 0.85

A new cable-tie based sternal closure system: description of the device, technique of implantation and first clinical evaluation. J Cardiothorac Surg (2012) 0.85

Deep sternal wound infection after cardiac surgery: Evidences and controversies. World J Crit Care Med (2015) 0.83

Tremendous bleeding complication after vacuum-assisted sternal closure. J Cardiothorac Surg (2011) 0.83

Mortality trends and the effects of débridement timing in the management of mediastinitis in the United States, 1998 to 2010. Plast Reconstr Surg (2014) 0.79

Improving public reporting and data validation for complex surgical site infections after coronary artery bypass graft surgery and hip arthroplasty. Open Forum Infect Dis (2014) 0.77

Quantifying the effect of complications on patient flow, costs and surgical throughputs. BMC Med Inform Decis Mak (2016) 0.75

Poststernotomy mediastinitis: a classification to initiate and evaluate reconstructive management based on evidence from a structured review. J Cardiothorac Surg (2014) 0.75

A National Study of the Impact of Initial Débridement Timing on Outcomes for Patients with Deep Sternal Wound Infection. Plast Reconstr Surg (2016) 0.75

Systematic review of factors influencing length of stay in ICU after adult cardiac surgery. BMC Health Serv Res (2016) 0.75

Socioeconomic effects of surgical site infection after cardiac surgery in Japan. Surg Today (2014) 0.75

Triclosan-coated sutures and sternal wound infections: a prospective randomized clinical trial. Eur J Clin Microbiol Infect Dis (2015) 0.75

A National Study of the Impact of Delayed Flap Timing for Treatment of Patients with Deep Sternal Wound Infection. Plast Reconstr Surg (2017) 0.75

The Impact of Deep Sternal Wound Infection on Mortality and Resource Utilization: A Population-based Study. World J Surg (2016) 0.75

Articles by these authors

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J (2005) 7.75

MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation (2007) 6.41

2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J (2014) 5.75

The safety of moderate hypothermic lower body circulatory arrest with selective cerebral perfusion: a propensity score analysis. J Thorac Cardiovasc Surg (2007) 3.08

Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med (2012) 2.86

Cryopreserved human allografts (homografts) for the management of graft infections in the ascending aortic position extending to the arch. Eur J Cardiothorac Surg (2012) 2.70

Long-term results after aortic valve-sparing operation (David I). Eur J Cardiothorac Surg (2012) 2.16

Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass? J Thorac Cardiovasc Surg (2003) 2.14

Transplantation and tracking of human-induced pluripotent stem cells in a pig model of myocardial infarction: assessment of cell survival, engraftment, and distribution by hybrid single photon emission computed tomography/computed tomography of sodium iodide symporter transgene expression. Circulation (2012) 2.13

Total aortic arch replacement with a novel four-branched frozen elephant trunk graft: first-in-man results. Eur J Cardiothorac Surg (2012) 2.11

Acute treatment of ST-segment-elevation myocardial infarction: is there a role for the cardiac surgeon? Ann Thorac Surg (2009) 2.11

Microbiologic analysis of peri-pancreatic fluid collected during EUS in patients with pancreatitis: impact on antibiotic therapy. Gastrointest Endosc (2013) 2.10

The ARCH Projects: design and rationale (IAASSG 001). Eur J Cardiothorac Surg (2013) 2.06

Long-term cardiac allograft valves after heart transplant are functionally and structurally preserved, in contrast to homografts and bioprostheses. J Heart Valve Dis (2006) 2.04

Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries. Catheter Cardiovasc Interv (2006) 1.97

TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome. Hum Mutat (2006) 1.93

Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model. Crit Care Med (2011) 1.87

Vascular complications in patients undergoing femoral cannulation for extracorporeal membrane oxygenation support. Ann Thorac Surg (2011) 1.81

Ascending aortic cannulation in acute aortic dissection type A: the Hannover experience. Eur J Cardiothorac Surg (2008) 1.80

Health-related quality of life and exercise tolerance in recipients of heart transplants and left ventricular assist devices: a prospective, comparative study. J Heart Lung Transplant (2010) 1.78

Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail (2010) 1.75

Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: a pilot study of 12 patients. Lancet (2012) 1.75

Elephant trunk procedure 27 years after Borst: what remains and what is new? Eur J Cardiothorac Surg (2011) 1.73

Ascending aortic cannulation for Stanford type A acute aortic dissection: another option. J Thorac Cardiovasc Surg (2003) 1.73

Sutureless Perceval S aortic valve replacement: a multicenter, prospective pilot trial. J Heart Valve Dis (2009) 1.70

Increased chimerism of bronchial and alveolar epithelium in human lung allografts undergoing chronic injury. Am J Pathol (2003) 1.69

Total aortic arch replacement with the frozen elephant trunk technique: 10-year follow-up single-centre experience. Eur J Cardiothorac Surg (2013) 1.61

Long-term outcome after pulmonary retransplantation. J Thorac Cardiovasc Surg (2006) 1.59

Cardiac retransplantation: is it justified in times of critical donor organ shortage? Long-term single-center experience. Eur J Cardiothorac Surg (2008) 1.54

Extended pulmonary resections of advanced thoracic malignancies with support of cardiopulmonary bypass. Eur J Cardiothorac Surg (2005) 1.54

Extended criteria donor lungs and clinical outcome: results of an alternative allocation algorithm. J Heart Lung Transplant (2013) 1.53

Predictors of aneurysmal formation after surgical correction of aortic coarctation. J Am Coll Cardiol (2002) 1.51

Pulmonary preservation with LPD and celsior solution in porcine lung transplantation after 24 h of cold ischemia. Eur J Cardiothorac Surg (2004) 1.51

Isolated surgical aortic valve replacement after previous coronary artery bypass grafting with patent grafts: is this old-fashioned technique obsolete? Eur J Cardiothorac Surg (2008) 1.51

Sutureless perceval aortic valve replacement: results of two European centers. Ann Thorac Surg (2012) 1.51

The impact of deep and moderate body temperatures on end-organ function during hypothermic circulatory arrest. Eur J Cardiothorac Surg (2011) 1.51

Surfactant function in lung transplantation after 24 hours of ischemia: advantage of retrograde flush perfusion for preservation. J Thorac Cardiovasc Surg (2002) 1.49

Higher frequencies of BCRP+ cardiac resident cells in ischaemic human myocardium. Eur Heart J (2012) 1.49

C1-esterase-inhibitor for primary graft dysfunction in lung transplantation. Transplantation (2014) 1.49

Anticoagulation for prosthetic heart valves during pregnancy: is low-molecular-weight heparin an alternative? Eur J Cardiothorac Surg (2002) 1.49

Total aortic arch replacement with the elephant trunk technique: single-centre 30-year results. Eur J Cardiothorac Surg (2013) 1.48

Scalable expansion of human pluripotent stem cells in suspension culture. Nat Protoc (2011) 1.46

Thrombus formation in a HeartMate II left ventricular assist device. J Thorac Cardiovasc Surg (2008) 1.46

A multi-modal intervention in management of left ventricular assist device outpatients: dietary counselling, controlled exercise and psychosocial support. Eur J Cardiothorac Surg (2012) 1.46

Microbial adhesion on membrane oxygenators in patients requiring extracorporeal life support detected by a universal rDNA PCR test. ASAIO J (2013) 1.44

Hypothermic circulatory arrest with moderate, deep or profound hypothermic selective antegrade cerebral perfusion: which temperature provides best brain protection? Eur J Cardiothorac Surg (2006) 1.44

Myocardial tissue engineering: the extracellular matrix. Eur J Cardiothorac Surg (2008) 1.43

Treatment of patients with recurrent or persistent infection of cardiac implantable electronic devices. Europace (2010) 1.43

One-year outcomes of the Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve (TRITON) trial: a prospective multicenter study of rapid-deployment aortic valve replacement with the EDWARDS INTUITY Valve System. J Thorac Cardiovasc Surg (2012) 1.43

The frozen elephant trunk technique: a new treatment for thoracic aortic aneurysms. J Thorac Cardiovasc Surg (2003) 1.42

Prevalence of CCR5Delta32 polymorphism in long-term survivors of heart transplantation. Transpl Immunol (2006) 1.42

Immunoglobulin G treatment of postcardiac surgery patients with score-identified severe systemic inflammatory response syndrome--the ESSICS study. Crit Care Med (2008) 1.42

Epithelial and Erythrocyte Microvesicles From Bronchoalveolar Lavage Fluid Are Elevated and Associated With Outcome in Chronic Lung Allograft Dysfunction. Transplantation (2015) 1.41

Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. J Thorac Cardiovasc Surg (2009) 1.41

Allogeneic CD4+CD25high T cells regulate obliterative bronchiolitis of heterotopic bronchus allografts in both porcinized and humanized mouse models. Transplantation (2015) 1.40

No evidence of transdifferentiation of human endothelial progenitor cells into cardiomyocytes after coculture with neonatal rat cardiomyocytes. Circulation (2006) 1.39

Clinical relevance of intracranial high intensity transient signals in patients following prosthetic aortic valve replacement. Eur J Cardiothorac Surg (2002) 1.38

Promoting Hand Hygiene Compliance. Dtsch Arztebl Int (2017) 1.37

Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization. Crit Care Med (2007) 1.35

Hypothermic circulatory arrest with selective antegrade cerebral perfusion in ascending aortic and aortic arch surgery: a risk factor analysis for adverse outcome in 501 patients. J Thorac Cardiovasc Surg (2008) 1.35

Bridge to lung transplantation with the novel pumpless interventional lung assist device NovaLung. J Thorac Cardiovasc Surg (2006) 1.33

Intramural hematoma of the aorta: predictors of progression to dissection and rupture. Circulation (2003) 1.30

Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur Heart J (2011) 1.29

Clostridium difficile in discharged inpatients, Germany. Emerg Infect Dis (2007) 1.29

Mesenchymal stem cells and progenitor cells in connective tissue engineering and regenerative medicine: is there a future for transplantation? Langenbecks Arch Surg (2011) 1.26

Health-related quality of life in two hundred-eighty lung transplant recipients. J Heart Lung Transplant (2005) 1.25

Aortic valve replacement in geriatric patients with small aortic roots: are sutureless valves the future? Interact Cardiovasc Thorac Surg (2013) 1.25

Implantation of a centrifugal pump as a left ventricular assist device through a novel, minimized approach: upper hemisternotomy combined with anterolateral thoracotomy. J Thorac Cardiovasc Surg (2011) 1.25

Plexiform lesions in pulmonary arterial hypertension composition, architecture, and microenvironment. Am J Pathol (2011) 1.23

Angiotensin II induces MMP-2 in a p47phox-dependent manner. Biochem Biophys Res Commun (2005) 1.22

Nonadherence with diet and fluid restrictions among adults having hemodialysis. J Nurs Scholarsh (2005) 1.22

Virus-associated hemophagocytic syndrome as a major contributor to death in patients with 2009 influenza A (H1N1) infection. Crit Care (2011) 1.21

Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study. Ann Thorac Surg (2008) 1.21

Safety of the use of Tissucol Duo S in cardiovascular surgery: retrospective analysis of 2149 patients after coronary artery bypass grafting. Eur J Cardiothorac Surg (2007) 1.20

Evolving strategies for treatment of acute aortic dissection type A. Circulation (2004) 1.20

Tissue engineering of small diameter vascular grafts. Eur J Vasc Endovasc Surg (2002) 1.19

Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc (2010) 1.16

Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro. Eur Heart J (2012) 1.16

Outbreaks in neonatal intensive care units - they are not like others. Am J Infect Control (2007) 1.15

Aortic valve reimplantation in ascending aortic aneurysm: risk factors for early valve failure. Ann Thorac Surg (2002) 1.15

Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression. J Heart Lung Transplant (2012) 1.15

Aortic root surgery in Marfan syndrome: Comparison of aortic valve-sparing reimplantation versus composite grafting. J Thorac Cardiovasc Surg (2004) 1.14

Technical innovations of carinal resection for nonsmall-cell lung cancer. Ann Thorac Surg (2006) 1.14

Identification of 29 novel and nine recurrent fibrillin-1 (FBN1) mutations and genotype-phenotype correlations in 76 patients with Marfan syndrome. Hum Mutat (2005) 1.14

Decade of aortic valve sparing reimplantation: are we pushing the limits too far? Circulation (2005) 1.13

Increase in left ventricular assist device thrombosis. N Engl J Med (2014) 1.13

Use of fresh decellularized allografts for pulmonary valve replacement may reduce the reoperation rate in children and young adults: early report. Circulation (2011) 1.12

Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors. Tissue Eng Part C Methods (2012) 1.11

Sternal microcirculation after skeletonized versus pedicled harvesting of the internal thoracic artery: a randomized study. J Thorac Cardiovasc Surg (2008) 1.10

Cryopreserved arterial homografts vs silver-coated Dacron grafts for abdominal aortic infections with intraoperative evidence of microorganisms. J Vasc Surg (2011) 1.09

Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation (2006) 1.09

Successful use of the HeartWare HVAD rotary blood pump for biventricular support. J Thorac Cardiovasc Surg (2010) 1.08

Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial. JAMA (2004) 1.07

Beliefs about hand hygiene: a survey in medical students in their first clinical year. Am J Infect Control (2011) 1.06

Surgical treatment of aberrant right subclavian artery (arteria lusoria) aneurysm using three different methods. Ann Thorac Surg (2006) 1.05

Intrapericardial migration of dislodged sternal struts as late complication of open pectus excavatum repairs. J Cardiothorac Surg (2011) 1.05

Evaluation of commercial universal rRNA gene PCR plus sequencing tests for identification of bacteria and fungi associated with infectious endocarditis. J Clin Microbiol (2011) 1.05